Major bleeding risks of different low‐molecular‐weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis
暂无分享，去创建一个
P. Reitsma | M. Kruip | S. Cannegieter | W. Lijfering | N. Wiersma | N. Rein | F. J. M. Meer | H. W. Vermaas | J. S. Biedermann | F. Meer | J. Biedermann | Marieke J. H. A. Kruip | P. Reitsma | F. J. M. V. D. Meer | Helga W. Vermaas